FAF2
FAS-associated factor 2
Also known as: ETEA, FAF2_HUMAN, KIAA0887, UBXD8, UBXN3B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96CS3
- Gene
- FAF2
- Ensembl
- ENSG00000113194
- Chromosome
- 5
- Canonical length
- 445 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum,Lipid droplets
OverviewNCBI Gene
The protein encoded by this gene is highly expressed in peripheral blood of patients with atopic dermatitis (AD), compared to normal individuals. It may play a role in regulating the resistance to apoptosis that is observed in T cells and eosinophils of AD patients. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
445 residues, UniProt reviewed canonical sequence.
>Q96CS3|FAF2
1 MAAPEERDLT QEQTEKLLQF QDLTGIESMD QCRHTLEQHN WNIEAAVQDR LNEQEGVPSV
61 FNPPPSRPLQ VNTADHRIYS YVVSRPQPRG LLGWGYYLIM LPFRFTYYTI LDIFRFALRF
121 IRPDPRSRVT DPVGDIVSFM HSFEEKYGRA HPVFYQGTYS QALNDAKREL RFLLVYLHGD
181 DHQDSDEFCR NTLCAPEVIS LINTRMLFWA CSTNKPEGYR VSQALRENTY PFLAMIMLKD
241 RRMTVVGRLE GLIQPDDLIN QLTFIMDANQ TYLVSERLER EERNQTQVLR QQQDEAYLAS
301 LRADQEKERK KREERERKRR KEEEVQQQKL AEERRRQNLQ EEKERKLECL PPEPSPDDPE
361 SVKIIFKLPN DSRVERRFHF SQSLTVIHDF LFSLKESPEK FQIEANFPRR VLPCIPSEEW
421 PNPPTLQEAG LSHTEVLFVQ DLTDELocalizationUniProt · AlphaFold · HPA
Whether an antibody against FAF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 23 nTPM
- thymus: 22 nTPM
- retina: 21 nTPM
- bone marrow: 20 nTPM
- testis: 20 nTPM
- liver: 20 nTPM
Single-cell type
- myonuclei: 166 nCPM
- neutrophils: 160 nCPM
- choroid plexus epithelial cells: 103 nCPM
- somatotrophs: 101 nCPM
- syncytiotrophoblasts: 101 nCPM
- early primary spermatocytes: 99 nCPM
Immune cell
- non-classical monocyte: 12 nTPM
- T-reg: 9.9 nTPM
- NK-cell: 9.2 nTPM
- basophil: 9.1 nTPM
- MAIT T-cell: 8.3 nTPM
- myeloid DC: 8 nTPM
Brain region
- choroid plexus: 33 nTPM
- hypothalamus: 26 nTPM
- pons: 26 nTPM
- cerebellum: 26 nTPM
- midbrain: 25 nTPM
- thalamus: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.22
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.52
- DepMap mean gene effect
- -0.45
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ERAD pathway
- lipid droplet organization
- proteasome-mediated ubiquitin-dependent protein catabolic process
- response to unfolded protein
- retrograde protein transport, ER to cytosol
- stress granule disassembly
Molecular functions
- lipase binding
- lipase inhibitor activity
- protein-macromolecule adaptor activity
- ubiquitin binding
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FAF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FAF2 as an antibody target. Whether an autoantibody or antibody against FAF2 could matter depends on whether native FAF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FAF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FAF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...